Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001370087-26-000005

Options or other derivatives

  • Director acquired 40,565 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Armitage James O Director 2026-06-11 Grant or award · Stock Options +40,565 228,104 D: show line 1 in the form
Loading xslF345X06/ownership.xml…